Postconditioning Attenuates Renal Ischemia-Reperfusion Injury by Preventing DAF Down-Regulation

Journal of Urology

Volumn 183, Issue 6, 2010, Pages 2424-2431

  Wang, Wei ^a   Tang, Tielong ^c   Zhang, Peng ^b   Bu, Hong ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

antigens, CD55; kidney; renal circulation; reperfusion injury; Wistar rats

Indexed keywords

CD56 ANTIGEN; COMPLEMENT COMPONENT C5A RECEPTOR; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; KIDNEY ISCHEMIA; KIDNEY NECROSIS; KIDNEY PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD55; DOWN-REGULATION; KIDNEY; MALE; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 77951879122     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.01.066     Document Type: Article

References (27)

1. Troppmann C., Gillingham K.J., Benedetti E., et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation 59 (1995) 962
2. Mehrabi A., Mood Zh A., Sadeghi M., et al. Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation. Nephrol Dial Transplant 22 suppl. (2007) viii54
3. Chen X., Liu X., Wan X., et al. Ischemic preconditioning attenuates renal ischemia-reperfusion injury by inhibiting activation of IKKbeta and inflammatory response. Am J Nephrol 30 (2009) 287
4. Serviddio G., Romano A.D., Gesualdo L., et al. Postconditioning is an effective strategy to reduce renal ischaemia/reperfusion injury. Nephrol Dial Transplant 23 (2008) 1504
5. Liu X., Chen H., Zhan B., et al. Attenuation of reperfusion injury by renal ischemic postconditioning: the role of NO. Biochem Biophys Res Commun 359 (2007) 628
6. Szwarc I., Soullier S., Gayrard N., et al. Ischemic postconditioning prevents ischemic acute renal failure. Transplant Proc 39 (2007) 2554
7. Arumugam T.V., Magnus T., Woodruff T.M., et al. Complement mediators in ischemia-reperfusion injury. Clin Chim Acta 374 (2006) 33
8. Chakraborti T., Mandal A., Mandal M., et al. Complement activation in heart diseases. Role of oxidants. Cell Signal 12 (2000) 607
9. Bonventre J.V. Complement and renal ischemia-reperfusion injury. Am J Kidney Dis 38 (2001) 430
10. Arumugam T.V., Shiels I.A., Woodruff T.M., et al. The role of the complement system in ischemia-reperfusion injury. Shock 21 (2004) 401
11. de Vries B., Kohl J., Leclercq W.K., et al. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 170 (2003) 3883
12. Thurman J.M., Ljubanovic D., Edelstein C.L., et al. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 170 (2003) 1517
13. Zhou W., Farrar C.A., Abe K., et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105 (2000) 1363
14. De Vries B., Matthijsen R.A., Wolfs T.G., et al. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation 75 (2003) 375
15. Yamada K., Miwa T., Liu J., et al. Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol 172 (2004) 3869
16. Turnberg D., Botto M., Lewis M., et al. CD59a deficiency exacerbates ischemia-reperfusion injury in mice. Am J Pathol 165 (2004) 825
17. Wang W., Yu P., Zhang P., et al. The infection of human primary cells and cell lines by human cytomegalovirus: new tropism and new reservoirs for HCMV. Virus Res 131 (2008) 160
18. Jablonski P., Howden B.O., Rae D.A., et al. An experimental model for assessment of renal recovery from warm ischemia. Transplantation 35 (1983) 198
19. Hughes J., Nangaku M., Alpers C.E., et al. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis. Am J Physiol Renal Physiol 278 (2000) F747
20. Buhl A.M., Avdi N., Worthen G.S., et al. Mapping of the C5a receptor signal transduction network in human neutrophils. Proc Natl Acad Sci U S A 91 (1994) 9190
21. Zhao Z.Q., Corvera J.S., Halkos M.E., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285 (2003) H579
22. Zheng X., Feng B., Chen G., et al. Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene. Am J Transplant 6 (2006) 2099
23. Damman J., Schuurs T.A., Ploeg R.J., et al. Complement and renal transplantation: from donor to recipient. Transplantation 85 (2008) 923
24. Peng Q., Li K., Sacks S.H., et al. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. Inflamm Allergy Drug Targets 8 (2009) 236
25. Riedemann N.C., Guo R.F., Laudes I.J., et al. C5a receptor and thymocyte apoptosis in sepsis. FASEB J 16 (2002) 887
26. Bao L., Osawe I., Puri T., et al. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur J Immunol 35 (2005) 2496
27. Arumugam T.V., Shiels I.A., Strachan A.J., et al. A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int 63 (2003) 134